| ²é¿´: 1306 | »Ø¸´: 4 | |||
liruihanÌú¸Ëľ³æ (ÕýʽдÊÖ)
|
[½»Á÷]
¡¾×ÊÔ´¡¿miRNA-96ÔÚÒÈÏÙ°©ÖпÉ×÷ΪһÖÖÖ×ÁöÒÖÖÆ»ùÒòÒÖÖÆKRAS ÒÑÓÐ4È˲ÎÓë
|
|
miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer Therapeutic applications of microRNA (miRNA) in KRAS-driven pancreatic cancers might be valuable, but few studies have explored this area. Here, we report that miR-96 directly targets the KRAS oncogene and functions as a tumor-suppressing miRNA in pancreatic cancer cells. Ectopic expression of miR-96 through a synthetic miRNA precursor inhibited KRAS, dampened Akt signaling, and triggered apoptosis in cells. In human clinical specimens, miR-96 was downregulated or deleted where an association with KRAS elevations was observed. In vitro and in vivo assays established that miR-96 decreased cancer cell invasion and migration and slowed tumor growth in a manner associated with KRAS downregulation. Our findings identify miR-96 as a potent regulator of KRAS, which may provide a novel therapeutic strategy for treatment of pancreatic cancer and other KRAS-driven cancers. Cancer Res; 70(14); 6015¨C25. ©2010 AACR |
» ²ÂÄãϲ»¶
ÖÐɽ´óѧ¸½ÊôµÚ°ËÒ½ÔºÕÐÊÕ2025¼¶²©Ê¿
ÒѾÓÐ12È˻ظ´
ÖÐɽ´óѧ¸½ÊôµÚ°ËÒ½ÔºÕÐÊÕ2025¼¶Ë¶Ê¿Ñо¿Éú
ÒѾÓÐ12È˻ظ´
ÖÐÎ÷Ò½½áºÏÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ232È˻ظ´
Çó¹ºHIB-1Bϸ°û
ÒѾÓÐ2È˻ظ´
ÖÐɽ´óѧ¸½ÊôµÚ°ËÒ½Ôº-ÕŻ۶«ÍŶÓÕÐÊÕ2026¼¶±£ÑÐ˶ʿÑо¿Éú
ÒѾÓÐ15È˻ظ´
ÖÐɽ´óѧ¸½ÊôµÚ°ËÒ½Ôº-ÕŻ۶«ÍŶÓÕÐÊÕ2026¼¶ÍÆÃâÑо¿Éú
ÒѾÓÐ7È˻ظ´
À¼ÖÝ´óѧÕÐÊÕ2026¼¶Ë¶Ê¿Ñо¿Éú(ÖÐɽ´óѧÁªÅࣩ
ÒѾÓÐ6È˻ظ´
ÖÐɽ´óѧ-À¼ÖÝ´óѧÁªºÏÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú
ÒѾÓÐ13È˻ظ´
ÖÐɽ´óѧ ÕŻ۶«ÍÅ¶Ó ³£ÄêÕÐÊÕ ²©Ê¿Ñо¿Éú
ÒѾÓÐ10È˻ظ´
ÖÐɽ´óѧ ÕŻ۶«ÍÅ¶Ó ³£ÄêÕÐÊÕ Ë¶Ê¿Ñо¿Éú
ÒѾÓÐ10È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
°ïæ¿´¿´ÕâÁ½ÖÖÎïÖÊÊÇʲô
ÒѾÓÐ4È˻ظ´
ʲôϸ¾ú¿ÉÒÔÒÖÖÆÃ¹¾úµÄÉú³¤Ñ½£¿
ÒѾÓÐ15È˻ظ´
Çë¸ßÊÖ°ïæ½â´ð£ºÎªÊ²Ã´UV¹â¶Ô·´Ó¦ÊÇ´Ù½ø×÷Ó㬿ɼû¹âÏÂÈ´ÊÇÒÖÖÆ×÷Óã¿O(¡É_¡É)Oлл
ÒѾÓÐ7È˻ظ´
ÖйúË®²ú¿ÆÑ§Ñо¿Ôº Ë®²úÉúÎïÓ¦ÓûùÒò×éÑо¿ÖÐÐÄ ÕÐÆ¸¹«¸æ
ÒѾÓÐ47È˻ظ´
ÇóÖúÈçºÎÒÖÖÆ»·Ñõ»¯Î↑»·
ÒѾÓÐ7È˻ظ´
ÎÒ¹ú¡°ÌæÄáÀࡱ£¨ÀÒ°±ËἤøÒÖÖÆ¼Á£©¿¹Ö×ÁöÒ©µÄÊг¡ÏÖ×´
ÒѾÓÐ15È˻ظ´
ɱ¾ú¼ÁµÄÒÖÖÆÖÐŨ¶ÈÒ»°ãÊǶàÉÙ £¿
ÒѾÓÐ9È˻ظ´
Ϊʲô¾ºÕùÐÔÒÖÖÆ¿ÉÒÔͨ¹ýÔö¼Óµ×ÎïµÄŨ¶È¶ø½â³ýÒÖÖÆ?
ÒѾÓÐ7È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÔºË±í´ïÑò»ùÒò£¬cDNA³¤¶ÈԼΪ3kb£¬»ùÒòΪһÖÖÓлîÐÔµÄø
ÒѾÓÐ15È˻ظ´
ÇóÖú »ùÒò¹¤³Ì¾ú±£²ØÎÊÌâ
ÒѾÓÐ11È˻ظ´
¡¾ÇóÖú¡¿´ó¼ÒÄܲ»ÄÜÍÆ¼ö¼¸¸ö¹úÍâ×ö»ùÒòתȾ£¨Ò©Îï¿ØÊÍ£©µÄÅ£ÈË£¿£¨ºÇºÇ£¬»ØÌû¾ÍËÍ~£©
ÒѾÓÐ39È˻ظ´
liruihan
Ìú¸Ëľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 11128.5
- ºì»¨: 5
- Ìû×Ó: 797
- ÔÚÏß: 37.8Сʱ
- ³æºÅ: 570219
- ×¢²á: 2008-06-06
- רҵ: ºôÎüϵͳÖ×Áö
xuede2005:ÏÂÃæÊÇ·ÒëÂð~ 2010-07-10 21:44:35
|
miRNA-96ÔÚÒÈÏÙ°©ÖпÉ×÷ΪһÖÖÖ×ÁöÒÖÖÆ»ùÒòÒÖÖÆKRAS ËäÈ»miRNAÔÚKRASÆô¶¯µÄÒÈÏÙ°©ÖеÄÖÎÁÆÓ¦ÓÿÉÄÜÓмÛÖµ£¬µ«¸Ã·½ÃæµÄÑо¿Ïà¶Ô½ÏÉÙ¡£±¾Ñо¿ÖÐÎÒÃDZ¨µÀÁËmiR-96ÔÚÒÈÏÙ°©ÖпÉ×÷ΪÖ×ÁöÒÖÖÆÐÔmiRNAÖ±½Ó°ÐÏòKRAS»ùÒò¡£miR-96ͨ¹ýÒ»ÖֺϳɵÄmiRNAǰÌåµÄÒìλ±í´ï¿ÉÒÑÖªKRAS£¬¼õ»ºAktÐźţ¬²¢Æô¶¯Ï¸°ûµÄµòÍö¡£ÔÚÈËÀàÁÙ´²±ê±¾ÖУ¬miR-96±í´ïϵ÷»òÏûʧ£¬¶øKRASÈ´±í´ïÉϵ÷¡£ÌåÄÚÍâÑо¿ÏÔʾmiR-96ͨ¹ýKRASϵ÷Ïà¹ØµÄ·½Ê½½µµÍ°©Ï¸°ûÇÖÏ®ºÍÇ¨ÒÆºÍ¼õµÍÖ×ÁöÉú³¤¡£ÎÒÃǵÄÑо¿·¢ÏÖmiR-96×÷ΪKRASÒ»¸öDZÔڵĵ÷¿ØÒò×Ó£¬ÔÚÒÈÏÙ°©»òÆäËûKRASÆô¶¯µÄ°©ÖÎÁÆÖпÉÌṩһÖÖеÄÖÎÁƲßÂÔ¡£ |
2Â¥2010-07-10 16:08:33
wangcheng2650
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 4116.5
- É¢½ð: 70
- Ìû×Ó: 790
- ÔÚÏß: 231.3Сʱ
- ³æºÅ: 567336
- ×¢²á: 2008-06-01
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯѧ

3Â¥2010-07-13 23:40:41
applesweet
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7853.3
- ºì»¨: 2
- Ìû×Ó: 2087
- ÔÚÏß: 457.7Сʱ
- ³æºÅ: 370327
- ×¢²á: 2007-05-13
- ÐÔ±ð: MM
- רҵ: ¿ÉÔÙÉúÓëÌæ´úÄÜÔ´ÀûÓÃÖеÄ
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
| ÇëÎÊÓйØÕâ·½ÃæµÄÁÙ´²±¨µÀô£¬Í¬Ñ§»¼ÉÏÕâÖÖ²¡£¬¼±ÇÐÏëÖªµÀÕâ·½ÃæºÃµÄÖÎÁÆ·½°¸£¬ÓÐÖªµÀÏà¹ØÑо¿µÄô£¬¶àлÌṩÏà¹Ø×ÊÁÏ£¡ |
4Â¥2010-07-15 15:34:00
zz200812
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 58
- Ìû×Ó: 56
- ÔÚÏß: 13Сʱ
- ³æºÅ: 1074540
- ×¢²á: 2010-08-14
- רҵ: ÉúÎïѧ
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
| ÕâÊÇÊôÓÚ»ù´¡ÐÔµÄÑо¿£¬ÒªÖªµÀÁÙ´²ÉϵÄÑо¿ÐèÒªµ½Ò½Ôº°¡ £¬¾¡Á¿Ôçµã°É£¬µ½±±¾©Ö×ÁöÒ½Ôº |
5Â¥2010-09-06 14:22:59













»Ø¸´´ËÂ¥